SVM Q1 2026 Earnings Strong EPS Beat Highlights Silver and Cost Management Gains ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline Jupiter Neurosciences JUNS Q4 2025 Earnings EPS Beat Masks ZeroRevenue Reality Shares Slide 12 Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status Titan America Q1 2026 Earnings EPS Misses Consensus Yet Shares Rally NEN Q4 2024 Earnings Partnership Reports 3612 EPS Amid Limited Disclosure